ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
알부민 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 8.5%로 99억 3,000만 달러로 성장합니다. 예측 기간의 성장은 간질환 유병률 증가, 재생의료 분야에서의 용도 확대, 노인 인구 증가, 진단 기술 발전, 외래 진료로의 의료 인프라 전환, 최적의 단백질 수준 유지의 중요성에 대한 인식 증가 등에 기인하는 것으로 보입니다. 예측 기간 중 주요 동향으로는 치료 용도 확대, 약물전달 시스템 채택 증가, 세포배양 배지 수요 증가, 맞춤형 의료 성장, 유전자 재조합 기술 발전, 저알부민혈증 치료에 대한 인식 증가, 혁신적인 알부민 기반 제품 연구개발에 대한 대규모 투자 등이 있습니다. 투자 등을 들 수 있습니다.
향후 5년간 8.5%의 성장률 예측은 이 시장에 대한 이전 예측에서 0.5%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 오스트리아 및 중국에서 공급되는 인간 혈청 알부민 및 혈장 단백질 용액의 비용을 상승시킴으로써 미국 의료 시스템을 저해하고, 중환자 치료 용품을 압박하며, 병원의 약국 지출을 증가시킬 것으로 예측됩니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
당뇨병 유병률 증가는 향후 알부민 시장의 성장을 촉진할 것으로 보입니다. 당뇨병은 고혈당 상태가 오래 지속되는 것이 특징인 대사성 질환으로 영양불량, 좌식 생활습관, 호르몬 상태, 비만 등의 요인으로 인해 증가 추세에 있습니다. 알부민은 중요한 바이오마커로서 당뇨병 관리에 중요한 역할을 하며, 인슐린 치료 지침, 혈당 조절 모니터링, 진단 보조, 당뇨병성 케톤산증(DKA) 등의 합병증 예측에 도움을 주고 있습니다. 알부민 수치를 정상으로 유지하는 것은 당뇨병을 효과적으로 관리하는 데 매우 중요합니다. 미국 국립의학도서관에 따르면 2021년 전 세계 당뇨병 유병률은 10.5%로 추정되며, 20-79세 인구 중 약 5억 3,660만 명이 앓고 있는 것으로 나타났습니다. 예측에 따르면 이 수치는 2045년에는 12.2%에 달하고, 약 7억 8,320만 명이 영향을 받을 수 있다고 합니다. 따라서 당뇨병 유병률 증가는 알부민 시장의 성장을 가속할 것으로 예측됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장의 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·Covid와 회복이 시장에 미치는 영향을 포함한다
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 알부민 시장 : PESTEL 분석(정치·사회·기술·환경·법적 요인, 촉진요인, 억제요인)
최종 용도 산업의 분석
세계의 알부민 시장 : 성장률 분석
세계의 알부민 시장 규모·성장률 : 실적(2019-2024년)
세계의 알부민 시장 규모·성장률 : 예측(2024-2029년, 2034년)
세계의 알부민 시장 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 알부민 시장 : 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
인간 혈청알부민
소 혈청 알부민
재조합 알부민
세계의 알부민 시장 : 용도별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
치료제
제제·백신
배지 성분
기타 용도
세계의 알부민 시장 : 판매 채널별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
B2C(Business-To-Consumer)
B2B(Business-To-Business)
세계의 알부민 시장 : 최종사용자별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
병원·진료소
제약·바이오테크놀러지 기업
연구기관
세계의 알부민 시장 : 인간 혈청알부민 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
혈장 유래 인간 혈청알부민
재조합 인간 혈청알부민
인간 혈청알부민 - 치료 용도(간질환, 화상)
인간 혈청알부민 - 약물전달·연구 용도
세계의 알부민 시장 : 소 혈청 알부민 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
소 혈청 알부민 - 실험실용(세포배양용)
소 혈청 알부민 - 진단 키트용
세계의 알부민 시장 : 재조합 알부민 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
재조합 인간 알부민 - 치료 용도
재조합 알부민 - 바이오의약품 제제 용도
재조합 알부민 - 화장품·퍼스널케어 용도
재조합 알부민 - 연구·진단 용도
제7장 지역별·국가별 분석
세계의 알부민 시장 : 지역별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
세계의 알부민 시장 : 국가별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
Takeda Pharmaceutical Company Limited(개요, 제품·서비스, 전략, 재무 분석)
Merck KGaA(개요, 제품·서비스, 전략, 재무 분석)
Baxter International Inc.(개요, 제품·서비스, 전략, 재무 분석)
제31장 기타 대기업과 혁신적 기업
CSL Limited
Grifols SA
Mitsubishi Tanabe Pharma Corporation
Octapharma AG
Kedrion S.p.A.
Biotest AG
Jiangxi Boya Bio-Pharmaceutical Co. Ltd.
BPL(Bio Products Laboratory)
Kamada Ltd.
Proliant Biologicals
SeraCare Life Sciences Inc.
HiMedia Laboratories
Albumedix Ltd.
Medxbio Pte Ltd.
Ventria Bioscience Inc.
제32장 세계 시장 : 경쟁 벤치마킹·대시보드
제33장 주요 기업인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력의 높은 국가·부문과 전략
알부민 시장 : 최신 기회를 제공하는 국가(2029년)
알부민 시장 : 최신 기회를 제공하는 부문(2029년)
알부민 시장 : 성장 전략(2029년)
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSA
영문 목차
영문목차
Albumin is a type of protein present in blood plasma, serum, muscle, egg whites, milk, and other animal substances, as well as in various plant tissues and fluids. It is a simple protein that is heat-coagulable and water-soluble, playing a vital role in maintaining fluid balance and transporting hormones, vitamins, and enzymes throughout the body.
The primary types of albumin are human serum albumin, bovine serum albumin, and recombinant serum albumin. Human serum albumin, found in blood plasma, helps maintain osmotic pressure and transports various substances such as hormones and fatty acids. Its applications include therapeutics, drug formulation, vaccines, and media components, distributed through channels such as business-to-customer (B2C) and business-to-business (B2B). The end users of albumin include hospitals and clinics, pharmaceutical and biotechnology companies, and research institutes.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The albumin research report is one of a series of new reports from The Business Research Company that provides albumin market statistics, including the albumin industry's global market size, regional shares, competitors with an albumin market share, detailed albumin market segments, market trends and opportunities, and any further data you may need to thrive in the albumin industry. This albumin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The albumin market size has grown strongly in recent years. It will grow from $6.57 billion in 2024 to $7.16 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to advancements in biotechnology, increased demand for plasma-derived therapies, expanding applications in pharmaceuticals, high prevalence of liver diseases, regulatory approvals for albumin-based products, and globalization of healthcare leading to wider market access.
The albumin market size is expected to see strong growth in the next few years. It will grow to $9.93 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the increasing prevalence of liver diseases, expanding applications in regenerative medicine, rising geriatric population, evolving diagnostic techniques, shifting healthcare infrastructure towards outpatient care, and growing awareness about the importance of maintaining optimal protein levels. Major trends in the forecast period include expanding therapeutic applications, rising adoption in drug delivery systems, increasing demand in cell culture media, growth in personalized medicine, advancements in recombinant technology, heightened awareness of hypoalbuminemia treatment, and significant investment in research and development for innovative albumin-based products.
The forecast of 8.5% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. healthcare system by increasing the cost of human serum albumin products and plasma protein solutions sourced from Austria and China, thereby straining critical care supplies and elevating hospital pharmacy expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of diabetes is poised to drive growth in the albumin market moving forward. Diabetes, a metabolic disorder characterized by prolonged high blood sugar levels, is on the rise due to factors such as poor nutrition, sedentary lifestyles, hormonal conditions, and obesity. Albumin plays a critical role in diabetes management as a significant biomarker, guiding insulin therapy, monitoring glycemic control, aiding diagnosis, and predicting complications such as diabetic ketoacidosis (DKA). Maintaining normal albumin levels is crucial for effectively managing diabetes. According to the National Library of Medicine, global diabetes prevalence was estimated at 10.5% in 2021, affecting approximately 536.6 million individuals aged 20-79 years. Projections suggest this figure could reach 12.2% by 2045, impacting about 783.2 million people. Therefore, the rising incidence of diabetes is expected to drive growth in the albumin market.
Leading companies in the albumin market are focusing on innovation, developing products such as animal- and human-origin-free recombinant albumin to meet increasing demand with advanced features. This type of albumin is produced using non-mammalian expression systems such as yeast and does not contain any animal- or human-derived components. For example, in March 2023, Albumedix, a UK-based manufacturer of recombinant human albumin (rHA), collaborated with Heartseed Inc., a Japan-based clinical-stage biotech company, to introduce Recombin as a critical excipient for Heartseed's investigational cell therapy, HS-001, during its first-in-human clinical trial. This partnership represents a significant milestone in advancing HS-001, promising innovative treatment approaches for various diseases. The use of recombinant technology ensures optimal performance and stability of the cell therapy, enhancing its potential for therapeutic success.
In September 2022, Sartorius AG, a Germany-based supplier of pharmaceutical and laboratory equipment, acquired Albumedix, strengthening its position in the expanding sector of advanced therapies and vaccines. This acquisition aligns Albumedix's innovative recombinant albumin technology with Sartorius' portfolio of cell culture media and process solutions, bolstering the company's offerings in the dynamic market landscape of advanced therapies. Albumedix Ltd. is a UK-based provider of high-quality recombinant human albumin solutions.
Major companies operating in the albumin market are Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Merck KGaA, Baxter International Inc., CSL Limited, Grifols SA, Mitsubishi Tanabe Pharma Corporation, Octapharma AG, Kedrion S.p.A., Biotest AG, Jiangxi Boya Bio-Pharmaceutical Co. Ltd., BPL (Bio Products Laboratory), Kamada Ltd., Proliant Biologicals, SeraCare Life Sciences Inc., HiMedia Laboratories, Albumedix Ltd., Medxbio Pte Ltd., Ventria Bioscience Inc., China Biologic Products Holdings Inc.
North America was the largest region in the albumin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the albumin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The albumin market consists of sales of egg albumin, plant-based albumin, and recombinant human albumin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Albumin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on albumin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for albumin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The albumin market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Human Serum Albumin; Bovine Serum Albumin; Recombinant Albumin
2) By Application: Therapeutics; Drug Formulation And Vaccines; Component Of Media; Other Applications
3) By Sales Channel: Business-To-Consumer (B2C); Business-To-Business (B2B)
4) By End-User: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Research Institutes
Subsegments:
1) By Human Serum Albumin: Plasma-Derived Human Serum Albumin; Recombinant Human Serum Albumin; Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns); Human Serum Albumin For Drug Delivery And Research Applications
2) By Bovine Serum Albumin: Bovine Serum Albumin For Laboratory Use (In Cell Culture); Bovine Serum Albumin For Diagnostic Kits; Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals
3) By Recombinant Albumin: Recombinant Human Albumin For Therapeutic Applications; Recombinant Albumin For Biopharmaceutical Formulation; Recombinant Albumin For Cosmetic And Personal Care Applications; Recombinant Albumin For Research And Diagnostic Applications
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Albumin Market Characteristics
3. Albumin Market Trends And Strategies
4. Albumin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Albumin Growth Analysis And Strategic Analysis Framework
5.1. Global Albumin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Albumin Market Growth Rate Analysis
5.4. Global Albumin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Albumin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Albumin Total Addressable Market (TAM)
6. Albumin Market Segmentation
6.1. Global Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
6.2. Global Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Therapeutics
Drug Formulation And Vaccines
Component Of Media
Other Applications
6.3. Global Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Business-To-Consumer (B2C)
Business-To-Business (B2B)
6.4. Global Albumin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Pharmaceutical And Biotechnology Companies
Research Institutes
6.5. Global Albumin Market, Sub-Segmentation Of Human Serum Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plasma-Derived Human Serum Albumin
Recombinant Human Serum Albumin
Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns)
Human Serum Albumin For Drug Delivery And Research Applications
6.6. Global Albumin Market, Sub-Segmentation Of Bovine Serum Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bovine Serum Albumin For Laboratory Use (In Cell Culture)
Bovine Serum Albumin For Diagnostic Kits
Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals
6.7. Global Albumin Market, Sub-Segmentation Of Recombinant Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Human Albumin For Therapeutic Applications
Recombinant Albumin For Biopharmaceutical Formulation
Recombinant Albumin For Cosmetic And Personal Care Applications
Recombinant Albumin For Research And Diagnostic Applications
7. Albumin Market Regional And Country Analysis
7.1. Global Albumin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Albumin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Albumin Market
8.1. Asia-Pacific Albumin Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Albumin Market
9.1. China Albumin Market Overview
9.2. China Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Albumin Market
10.1. India Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Albumin Market
11.1. Japan Albumin Market Overview
11.2. Japan Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Albumin Market
12.1. Australia Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Albumin Market
13.1. Indonesia Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Albumin Market
14.1. South Korea Albumin Market Overview
14.2. South Korea Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Albumin Market
15.1. Western Europe Albumin Market Overview
15.2. Western Europe Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Albumin Market
16.1. UK Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Albumin Market
17.1. Germany Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Albumin Market
18.1. France Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Albumin Market
19.1. Italy Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Albumin Market
20.1. Spain Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Albumin Market
21.1. Eastern Europe Albumin Market Overview
21.2. Eastern Europe Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Albumin Market
22.1. Russia Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Albumin Market
23.1. North America Albumin Market Overview
23.2. North America Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Albumin Market
24.1. USA Albumin Market Overview
24.2. USA Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Albumin Market
25.1. Canada Albumin Market Overview
25.2. Canada Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Albumin Market
26.1. South America Albumin Market Overview
26.2. South America Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Albumin Market
27.1. Brazil Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Albumin Market
28.1. Middle East Albumin Market Overview
28.2. Middle East Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Albumin Market
29.1. Africa Albumin Market Overview
29.2. Africa Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Albumin Market Competitive Landscape And Company Profiles
30.1. Albumin Market Competitive Landscape
30.2. Albumin Market Company Profiles
30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Albumin Market Other Major And Innovative Companies
31.1. CSL Limited
31.2. Grifols SA
31.3. Mitsubishi Tanabe Pharma Corporation
31.4. Octapharma AG
31.5. Kedrion S.p.A.
31.6. Biotest AG
31.7. Jiangxi Boya Bio-Pharmaceutical Co. Ltd.
31.8. BPL (Bio Products Laboratory)
31.9. Kamada Ltd.
31.10. Proliant Biologicals
31.11. SeraCare Life Sciences Inc.
31.12. HiMedia Laboratories
31.13. Albumedix Ltd.
31.14. Medxbio Pte Ltd.
31.15. Ventria Bioscience Inc.
32. Global Albumin Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Albumin Market
34. Recent Developments In The Albumin Market
35. Albumin Market High Potential Countries, Segments and Strategies
35.1 Albumin Market In 2029 - Countries Offering Most New Opportunities
35.2 Albumin Market In 2029 - Segments Offering Most New Opportunities
